basel cocktail + fluconazole + ciprofloxacin + paroxetine

This is a combination therapy consisting of the "Basel cocktail" (a set of probe drugs used to assess cytochrome P450 enzyme activity), fluconazole (an antifungal agent), ciprofloxacin (a broad-spectrum fluoroquinolone antibiotic), and paroxetine (a selective serotonin reuptake inhibitor antidepressant). The combination does not correspond to a single approved pharmaceutical product but rather represents a regimen likely used in clinical pharmacology research or for specific therapeutic purposes. Each component has distinct mechanisms of action: - **Fluconazole** inhibits fungal cytochrome P450 enzyme 14α-demethylase, disrupting ergosterol synthesis and compromising fungal cell membrane integrity[4]. - **Ciprofloxacin** inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication in susceptible bacteria[5][8]. - **Paroxetine** selectively inhibits the reuptake of serotonin into presynaptic neurons, increasing synaptic serotonin levels. The "Basel cocktail" itself typically includes several probe drugs for CYP enzyme phenotyping; its exact composition may vary.